Rationale: Diverse B cell responses and functions may be involved in atherosclerosis. Protective antibody responses, such as those against oxidized lipid epitopes, are thought to mainly derive from T cell-independent innate B cell subsets. In contrast, both pathogenic and protective roles have been associated with T cell-dependent antibodies, and their importance in both humans and mouse models is still unclear.
T he subendothelial accumulation of low-density lipoprotein (LDL) is central to the initiation and progression of atherosclerotic plaques. Modification of LDL, and a consequent shift in recognition, uptake and intracellular processing (or lack of) by phagocytes, plays a key role in driving atherosclerosis. In contrast to early phagocytosis of apoptotic cells, which is anti-inflammatory, secondary necrosis can be highly proinflammatory, 1 recruiting and activating immune cells. A current paradigm for atherosclerosis proposes that the combination of extracellular lipid accumulation, foam cell formation, and defective efferocytosis leads to a nonresolving loop of inflammation, debris accumulation, and response to injury.
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Oxidative modifications of LDL and cellular membranes create immunogenic epitopes recognized by antibodies. 2 B cell antibody responses can be divided broadly into 3 categories. Innate-like IgM production, primarily from B1 cells but also marginal zone B cells, occurs against common molecular pattern antigens, such as malondialdehyde (MDA) and phosphorylcholine, and is present perinatally and even in germ-free mice. 3 Responses to other antigens also initially result in IgM production from short-lived plasmablasts and plasma cells but then undergo various forms of adaptation. T cell-independent responses can adapt via class-switching of IgM to other isotypes, such as IgA. T cell help from antigen-specific CD4 + T cells leads to both class-switching and multiple rounds of affinity maturation within germinal centers (GCs) of lymphoid organs, resulting in high In mice, many studies suggest IgM antibodies provide an important atheroprotective layer. [11] [12] [13] [14] [15] The specific effect of deleting IgM antibodies (rather than B cells in general) was first addressed by Lewis et al. 16 Mice lacking soluble IgM (but not B cell surface IgM or other isotypes of antibodies) have increased atherosclerosis. 16 However, in a more recent study using soluble IgM (sIgM −/− )/Ldlr −/− mice, we demonstrated that the enhanced atherosclerosis was a result of IgE accumulation in the circulation because anti-IgE injections completely reversed the phenotype. 17 IgE accumulates because sIgM −/− mice have a significant reduction in IgE receptor (CD23)-expressing B cells, leading to mast cell activation and proatherogenic inflammation. This raises important questions about the direct role of IgM or related downstream biological events in mediating atheroprotection. IgG antibodies against modified LDL may also be protective, for example, passive transfer of a human IgG1 against an MDA-modified apoB100 peptide reduces mouse atherosclerosis. 18 Recombinant Fab and single chain forms of anti-MDA-LDL antibodies, which lack the normal Fc-mediated effects of antibodies, also reduce foam cell formation and atherosclerosis. 19 However, several studies also implicate a pathogenic role for IgG in atherosclerosis, albeit indirectly, [20] [21] [22] and vascular pathologies, such as chronic cardiac rejection and large vessel vasculitis, are thought to be driven by pathogenic autoantibodies. 23, 24 Emerging paradigms reveal many non-antibody-dependent functions of B cells that could play important roles in atherosclerosis. [25] [26] [27] We and others have shown follicular B2 cell interactions with CD4 + T cells, antagonized by marginal zone B2 cells, promote pathogenic T cell responses in the atherosclerotic setting. [28] [29] [30] [31] [32] [33] Few models have, therefore, addressed the specific role of antibodies in isolation without impacting on other B cell functions. Altogether, it is hard to predict the 
Novelty and Significance
What Is Known?
• The adaptive immune response by B and T cells is associated with multiple pathogenic and protective responses in atherosclerosis.
• Natural IgM antibodies against OSE may protect against atherosclerosis, whereas B cell depletion studies suggest alternative pathogenic roles.
• Helper T cells mount important cellular responses during plaque development ,but the importance of T cell-driven humoral responses is unclear.
What New Information Does This Article Contribute?
• Severe attenuation of plasma cell antibody secretion leads to enhanced atherosclerosis.
• Depletion of helper CD4 + T cells leads to a significant reduction in antibodies to OSE and increased atherosclerosis in WT but not antibodydeficient mice.
• Larger atherosclerotic plaques in antibody-deficient or anti-CD4-depleted mice have a more vulnerable phenotype, with larger necrotic cores and reduced collagen deposition.
Investigating mechanisms controlling accumulation of oxidized LDL and necrotic cells is central to understanding atherosclerotic plaque development and the susceptibility to rupture. Protective antibody responses, such as those against oxidized lipid epitopes, are thought to mainly derive from helper T cell-independent innate-like responses. In contrast, recent evidence suggests that adaptive B cells promote atherosclerosis. Using a novel mouse model specifically targeting production of antibodies without depleting the immune cells, we show that antibody deficiency leads to larger atherosclerosis plaques with increased features of plaque vulnerability. Depletion of helper T cells that modulate and support antibody responses alone was sufficient to enhance atherosclerosis and increase markers of vulnerability. However, depletion of helper T cells had no effect on atherosclerosis severity and plaque vulnerability in antibody-deficient mice. T cell depletion reduced, as expected, T cell-dependent antibodies but also unexpectedly attenuated production of oxidation-specific IgM antibodies, previously considered to be T cell-independent. Our data highlight the potential importance of CD4+ T cells in OSE antibody responses and that these responses are critical in limiting necrotic core development in mice. The findings add novel insight into the biology of adaptive immune responses in atherosclerosis and have potential implications for therapeutic strategies, such as vaccination. July 21, 2017
effects of total antibody deficiency on atherosclerosis. We designed experiments to target plasma cell antibody production specifically. Plasma cells undergo a profound transcriptional reprogramming during differentiation from activated B cells; a prominent set of genes induced in plasma cells are regulators of the endoplasmic reticulum stress pathway, which expands antibody secretion capacity. 34 A key transcription factor is XBP1 (X-box-binding protein-1), and previous studies have characterized in detail that mice with B cell-specific Xbp1 genetic deletion display a specific defect in antibody production. [35] [36] [37] Using this model under the atherosclerotic Ldlr −/− background, we demonstrate that Xbp1-dependent plasma cell responses have a prominent antiatherosclerotic influence.
Methods

Mice
CD79a
Cre mice were originally created in the Reth lab 38 and were obtained from Jackson Laboratories (020505). Xbp1 fl/fl mice were originally created in the Glimcher lab 39 and were a gift of Prof A. Kaser, University of Cambridge. Ldlr −/− mice were originally obtained from Jackson Laboratories (002207). A total of 53 male Ldlr −/− mice were used in the study. Antigen-specific antibody responses were induced by immunization with nitrophenyl (NP)-chicken gamma globulin (100µg; Biosearch) in alum. Creation of bone marrow chimeric mice, atherosclerosis experiments, and anti-CD4 depletion have been previously described. 40 Mice from different experimental groups were cohoused for atherosclerosis experiments. This research has been regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 after ethical review by the University of Cambridge Animal Welfare and Ethical Review Body.
Plaque and Serum Analysis
To assess plaque size and composition, aortic root cryosections were stained with Oil red O (Sigma), CD3 (Dako), MOMA2 (monocyte/macrophage; Biorad), α-smooth muscle actin (Sigma), IgM (Biolegend), IgG 1 (Bethyl Laboratories), picrosirius red (Sigma), and by TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling; Roche). Oil red O-stained aortic arches were dissected and imaged en face. Images were analyzed using ImageJ (National Institutes of Health). Serum antibodies were analyzed using kits from Bethyl Laboratories and total cholesterol using a cholesterol RTU kit (Biomerieux). Triglyceride levels were measured using LabAssay kit (Wako). Antibodies against oxidation-specific epitopes (OSE) were measured as previously described.
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Immune Cell Phenotyping
Flow cytometry of single cell suspensions was performed as previously described. 40 Flow cytometry antibodies are detailed in Online Table I and gating strategies are outlined in Online Table II . For ELISpot assays, multiscreen 96-well filter plates (Millipore) were coated with anti-mouse total IgM or IgG (Bethyl Laboratories) overnight, blocked with phosphate-buffered saline/1% bovine serum albumin, then incubated with 10 4 -10 6 bone marrow or spleen cells overnight. For NP-specific antibody detection, plates were coated with NP-bovine serum albumin (Biosearch). Staining was revealed with anti-mouse IgG-horseradish peroxidase (Southern Biotech) or anti-mouse IgM-horseradish peroxidase (Bethyl Laboratories) and 3,3ʹ,5,5ʹ-tetramethylbenzidine substrate. Plates were analyzed using an Immunospot reader (CTL Technologies). Regulatory T cell suppression assays were conducted using magnetically purified cells (Miltenyi) as previously described.
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Statistics
Data were analyzed in GraphPad Prism (La Jolla, CA) using unpaired t test (or Mann-Whitney U test for data sets not passing normality), 1-way ANOVA, or 2-way ANOVA, as appropriate. A P value <0.05 was considered significant.
Results
Xbp1 Deficiency in B Cells Attenuates Plasma Cell Antibody Production
To obtain a mouse model with a specific defect in antibody secretion, we recreated a previously reported B cell-specific deletion of the transcription factor XBP1, which is required for terminal plasma cell differentiation but not antecedent stages of B cell development, maintenance of mature B cells, GC B cell, or memory B cell formation. [35] [36] [37] Mice carrying a floxed allele of the Xbp1 gene were crossed to Cd79a
Cre/+ mice that express Cre only in B cells. 38 To confirm the phenotype of these mice, we performed ELISpot analysis of total IgM and IgG-producing bone marrow plasma cells (Online Figure IA) Figure IA) . In addition to this baseline phenotype, we also analyzed the antigen-specific response. Xbp1 B-cKO mice and WT littermates were immunized with NP-chicken gamma globulin, and after 7 days, bone marrow NP-specific plasma cells and serum NP-specific IgG were analyzed. Compared with phosphate-buffered saline-immunized controls in which NP-specific responses were undetectable, we detected NPspecific IgG1 secreting plasma cells in WT mice. In Xbp1 B-cKO mice, NP-specific plasma cells were present but reduced around 2-fold (Online Figure IB) . NP-specific IgG1 levels in the serum from the same mice were around 16-fold less in Xbp1 B-cKO than WT mice, with no detectable antibodies in phosphate-buffered saline-immunized mice (Online Figure IC) . The difference in antibody titer was, therefore, more severely affected than the difference in antibody producing plasma cells, consistent with the idea that plasma cells can form in the absence of XBP1, but their antibody production is severely impaired. As previously reported, 35 total number of CD138 + B220 − plasma cells were normal in bone marrow by flow cytometry (Online Figure ID) .
B Cell Deletion of Xbp1 in Atherosclerotic Mice Specifically Attenuates Antibody Production
To determine the impact of antibody deficiency on atherosclerosis, we then used 
/Xbp1
B-cKO chimeras with depleting anti-CD4 antibodies for the duration of the western diet feeding. 40 Littermate (and cohoused) Ldlr −/− recipients were split evenly among the 4 groups. In both groups of mice treated with anti-CD4 antibodies, depletion was maintained to a high level between injections, with only minor levels of CD4 + T cell recovery detected immediately before the subsequent injection (Online Figure IE) .
To confirm that defective antibody production seen in Xbp1 B-cKO mice was reproduced in atherosclerotic
Ldlr
−/− chimeras, we analyzed total IgG, IgE, IgA, and IgM in serum using specific ELISAs. We also measured subtypes of IgG, including T cell-dependent total IgG2c and T cellindependent IgG3. All isotypes were significantly reduced in Figure II) . XBP1 is primarily expressed during plasma cell differentiation and is not reported to have major functions in B cells. However, the lack of antibodies may have feedback influences on the B cell compartment. We, therefore, performed detailed flow cytometry phenotyping of B cell subsets in bone marrow, spleen, and peritoneum, including peritoneal B1 cells and splenic marginal zone B cells that are known to regulate atherosclerosis. 13, 33, 41 There were no differences in bone marrow B cell fractions in Ldlr
B-cKO mice or after anti-CD4 depletion (Online Figure IIIA) . In the spleen, there was an expansion of marginal zone B cells ( Figure 1I) 
/Xbp1
B-cKO mice, but this difference did not reach significance (Online Figure IIIB) . This expansion of innate-like B cells was specific to the spleen because no Figure 1 . B cell deletion of X-box-binding protein-1 (Xbp1) in atherosclerotic mice specifically attenuates antibody production. Antibodies and B cell system in Ldlr/wild-type (WT) or Ldlr/XBP B-cKO mice tread with (αCD4) or without anti-CD4 antibodies. A through H, Serum levels of specific antibody isotypes. I, B cell subsets as defined by flow cytometry (Online Table II) 
B-cKO mice did not display significant differences in follicular B2 cells, whereas anti-CD4 depletion led to an expansion of splenic follicular B2 cells in WT but not cKO chimeras ( Figure 1I ). Ldlr
B-cKO mice displayed no changes in spleen GC B cells or in plasma cell numbers in bone marrow ( Figure 1J and 1K) . In contrast, GC B cells were absent from both anti-CD4-treated groups ( Figure 1J ), providing functional evidence of successful CD4 depletion. This is also consistent with a severe reduction in GC-dependent IgG1 and IgG2c antibody levels ( Figure 1G ). Anti-CD4-treated mice tended to have less plasma cells, which was significant in Ldlr
B-cKO ( Figure 1K ). There was also a trend toward an increased proportion of IgM + plasma cells in Ldlr −/− /WT mice treated with anti-CD4 compared with Ldlr/WT controls, consistent with less class-switched responses (Online Figure IIID) .
Xbp1 Deficiency in B Cells Does Not Modulate Systemic T Cell Immune Responses
We and others have previously shown that global B2 cell or specific marginal zone B cell depletion can have significant impacts on CD4 + T cell effector responses that promote atherosclerosis. [28] [29] [30] 33 Total CD4 + and CD8 + T cell numbers were not different between Ldlr 
/Xbp1
B-cKO groups ( Figure 2D) ; however, we observed a significant reduction in MHCII (major histocompatibility complex) levels on both CD8α + and CD11b + cDCs but not plasmacytoid DCs ( Figure 2E ). This difference was not observed in anti-CD4-depleted mice ( Figure 2E ) and MHCII is not expected to have any significant function in those mice. The modest reduction of MHCII in Ldlr −/−
B-cKO mice does not seem to have impacted on effector T cell responses (Figure 2A through 2C ), but we hypothesized that differences in DC antigen presentation could have compromised regulatory T cell function. 
B-cKO mice had a specific deficiency in antibody production without impacting systemically on cellular immune responses.
Xbp1 Deficiency in B Cells Enhances Atherosclerosis
The development of atherosclerosis was quantified in the aortic root and the aortic arch by oil red O staining ( Figure 3A 
/Xbp1
B-cKO mice treated with anti-CD4 ( Figure 3B ). The same pattern was seen in the aortic arch, although both CD4-depleted groups had higher levels of atherosclerosis ( Figure 3C ). The levels of circulating total cholesterol or triglycerides were not different between any group (Online Figure IVC and IVD) . The body weight of Ldlr −/−
B-cKO mice was higher than in other groups-an effect not observed in anti-CD4-treated groups (Online Figure IVE) .
Xbp1 Deficiency in B Cells and Anti-CD4 Depletion Reduce Oxidized Epitope-Specific Antibodies
Based on increased atherosclerosis in both Ldlr
B-cKO and anti-CD4-treated mice, and decreased levels of IgM, we determined the levels of OSE-specific antibodies. IgM levels to MDA, MDA acetaldehyde, and phosphorylcholine epitopes (conjugated to bovine serum albumin) are presented in Figure 4A through 4C and showed a similar trend to total antibody levels (Figure 1) . A prototypic B1 cell natural antibody, T15, is detected using anti-idiotypic AB1-2 antibodies. Again, as expected, serum T15 titers were significantly reduced in Ldlr −/−
/Xbp1
B-cKO mice ( Figure 4D ). Interestingly, anti-CD4 depletion in Ldlr −/− /WT mice also resulted in significantly reduced levels ( Figure 4D ). Serum IgG antibody titers to MDA, MDA acetaldehyde, and phosphorylcholine were severely reduced by B cell XBP1 deficiency and anti-CD4 depletion ( Figure 4E through 4G) . We also analyzed IgG subtype antibodies to MDA-LDL ( Figure 4H ). All isotypes except IgG3 were significantly reduced in Ldlr −/−
B-cKO mice. Anti-CD4 depletion had a larger effect on IgG2c than IgG1 or IgG2b, consistent with effects on total IgG levels ( Figure 1) . Thus, all treatment groups with enhanced atherosclerosis displayed an attenuation of circulating anti-OSE antibody levels.
XBP1 Deficiency in B Cells Increases Apoptotic Cell Accumulation and Necrotic Core
We next analyzed the plaque composition in Ldlr 
/Xbp1
B-cKO mice to investigate the mechanisms involved in enhanced atherosclerosis. Although serum antibody levels were significantly reduced in experimental groups (Figure 1 
B-cKO mice ( Figure 5A ). In anti-CD4-depleted mice, IgM was also significantly reduced ( Figure 5A ), consistent with results from serum ELISAs (Figure 1 
B-cKO and both anti-CD4-treated groups had significantly reduced collagen deposition ( Figure 5C ). A potential protective function for antibodies in atherosclerosis is the binding and removal of apoptotic or (secondary) necrotic cells. 2 In support of this, the necrotic core area was significantly increased in Ldlr −/− /Xbp1
B-cKO
, as was the level of TUNEL staining within plaques ( Figure 5D and 5E). Plaque necrotic core and TUNEL staining were also increased in anti-CD4-depleted Ldlr −/− /WT mice ( Figure 5D and 5E). Because normal plaque progression can heavily influence plaque composition, we determined to what extent overall plaque size in each mouse contributed to the difference in plaque composition we observed. Thus, we normalized plaque area data of each mouse (data in Figure 3A ) by dividing by the average plaque size for that mouse. Plaque size seemed to account for the majority of differences in CD3 + T cell content between Ldlr −/− /WT and Ldlr −/− /Xbp1 B-cKO mice (Online Figure VE) . However, the levels of necrotic core and TUNEL + staining were still significantly increased in both Ldlr −/− /Xbp1 B-cKO (Online Figure VF and VG). The reduction in plaque collagen was even more apparent after adjustment for plaque size (Online Figure VH) . As an alternative analysis, we also plotted mouse plaque size against percentage necrotic core and percentage collagen area using only mice with plaques of overlapping levels of atherosclerosis (Online Figure Vl) . Plaques of Ldlr −/− /Xbp1 B-cKO mice displayed higher relative necrotic core area and lower collagen levels than Ldlr −/− /WT mouse plaques even though levels still varied with plaque size. This supports the hypothesis that reduction in systemic antibodies led to reduced antibody binding within atherosclerotic plaques, leading to enhanced accumulation of necrotic cells.
Discussion
One of the hallmarks of atherosclerosis is the accumulation and failed clearance of oxidized LDL and apoptotic cell debris within the atherosclerotic plaque. Oxidized LDL and apoptotic debris are recognized by specific antibodies present in both plasma and atherosclerotic plaque. Most recently, protective antibody responses have been specifically associated with innate (T cell independent) pathways, such as natural IgM. 13, 44 Our study is the first to specifically target plasma cell antibody secretion and to determine the effects of antibody deficiency in the presence of all B cell subsets and lymphoid organs. Our results suggest that protective antibody responses depend on XBP1-driven plasma cell maturation to a highly secretory state and also on CD4 + T cells. We propose that a T cell-driven expansion of antibody production is a key protective pathway in response to hyperlipidemia. Both cognate and noncognate T cell help, which has been implicated in natural IgM expansion, may contribute to these responses.
The B cell receptor senses antigen, which in conjunction with secondary signals, induces the activation of antigen-specific B cells, leading to proliferation and subsequent differentiation into plasma cells. Plasma cells undergo a profound transcriptional reprogramming, develop extensive rough endoplasmic reticulum and Golgi systems, and upregulate both protein synthesis and folding machinery, allowing huge levels of antibody secretion. 34 The loss of XBP1 prevents the final stages of this differentiation/maturation pathway, leading to plasma cells with severely attenuated secretory capacity. 35, 36 We took advantage of this phenotype to specifically interrogate the impacts on atherosclerosis, driven by the chronic and myriad accumulation of oxidized lipid antigens. It is reasonable to presume that the antigen burden is high in western diet-fed Ldlr −/− mice, and, thus, antibody consumption would be correspondingly rapid. Although low levels of antibodies are produced in Ldlr
B-cKO mice (Figures 1  and 4 ; Online Figure I ), our results demonstrate this severe reduction in production is sufficient to significantly accelerate plaque growth (Figure 3 ) and promote a more unstable plaque status ( Figure 5 ). Although we cannot completely exclude an alternative impact of XBP1 deficiency on B cell functions independent of plasma cell antibody secretion, we think that together with previous articles, our data strongly indicate that other direct effects on B cell functions are minor. A previous report using transgenic MD4 hen egg lysozyme-specific B cells suggested a defect in plasma cell homing driven by CXCR4 36 ; however, this was not reproduced in mice with normal B cell repertoires. 37 Although no other studies have previously addressed the effects of a specific defect in plasma cells, 2 previous articles reported enhanced atherosclerosis in mice lacking the secreted form of IgM. 16, 17 Indirect but compelling evidence for the importance of IgM is also provided by studies showing enhanced atherosclerosis in IL5-deficient mice that have reduced IgM 11 and reduced atherosclerosis in SiglecG-deficient mice that have increased IgM. 44 In addition, passive transfer of polyclonal IgM reduces atherosclerosis in ApoE −/− mice. 12 However, in sIgM −/− Ldlr −/− mice, impaired clearance of IgE promotes atherosclerosis, rather than direct local effects of IgM deficiency. 17 Compared with sIgM −/− mice, Ldlr
B-cKO mice have a further deficiency, both in IgE and in all other isotypes of antibodies ( Figure 1A through 1E) . This suggests the possibility that IgG antibodies of the same specificity, presumably for oxidized epitopes, such as MDA or phosphorylcholine, may also make a significant antiatherosclerotic contribution. Studies showing that pneumoccocal immunization of Ldlr −/− mice lead to a selective expansion of phosphorylcholine-specific IgM antibodies and reduced atherosclerosis initially suggested an important role for IgM antibodies. 15 However, phosphorylcholine-and MDA-based vaccination strategies that demonstrated an induction of both specific IgM and IgG antibodies also resulted in robust lesion reduction. 43, 45 A previous study demonstrated that IgG antiphosphorylcholine binds distinct oxidized epitope-containing determinants on apoptotic cells. 15 Therefore, one explanation could be that the combination of IgM and IgG is most protective.
The complete lack of all B cell subsets (and, therefore, antibodies) was reported to increase atherosclerosis, both in µMT/Apoe −/− mice 46 and after bone marrow transfer of µMT bone marrow into Ldlr −/− recipients. 47 In contrast, a recent study showed reduced atherosclerosis in µMT/Apoe −/− mice. 48 An alternative strategy resulting in attenuated B cell responses is splenectomy. Splenectomy enhanced atherosclerosis 13, 46 and the plaque phenotype was similar to Ldlr
B-cKO mice ( Figure 5 ). The effect of splenectomy can be reversed by transfer of splenic B cells from Apoe −/− mice 46 or by peritoneal B1a cell transplant. 13 Given these discrepancies, and the influence The influence of CD4 + T cells on atherosclerosis is well known to depend on the opposing influences of different subsets of T eff . Th1-polarized CD4 + T cells producing cytokines, such as IFN-γ, interleukin-12 (IL-12), and IL-18, promote atherosclerosis, whereas regulatory T cells producing transforming growth factor-β (TGF-β) and IL-10 dampen plaque growth. 49, 50 Here, we also suggest that CD4 + T cells influence atherosclerosis through regulation of antibody responses. Anti-CD4 depletion reduced IgM, IgG1, and IgG2c antibody levels but neither total IgG nor IgG3 (Figure 1 ). Anti-CD4 depletion enhanced atherosclerosis, but the combination of anti-CD4 depletion and antibody deficiency had no additive effect on atherosclerosis development (Figure 3) . Anti-OSE antibodies in WT mice are primarily produced by B1 cells, but adaptive B2 cell clones with similar specificity are induced by immunization 51 and based on the presence of class-switched IgG antibodies, also expand and become plasma cells in atherosclerotic mice. 52 In our study, antibodies against OSE were significantly reduced in a similar way to total antibody levels by both XBP1 deficiency and anti-CD4 depletion. Previously, MDA-LDL immunization induced a prominent Th2-type CD4 + T cell response and an IL-5 dependent increase in antioxLDL IgM production, 11 which in vitro was solely produced in response to IL-5 by B1a cells. Our study suggests that endogenous protective responses to oxidized LDL epitopes may also be enhanced (in a noncognate manner) by CD4 + T cells. In a similar way to immunization, western diet feeding (as used in this study) can switch the T cell response in atherosclerotic mice from Th1 to Th2, 53 and a recent study with human B cells showed that CD4 + T cells greatly enhance anti-MDA and anti-phosphorylcholine antibody production in vitro. 54 We, therefore, conclude that CD4 + T cells may play an important and significant role in antiatherogenic antibody production. Given the previously demonstrated importance of regulatory T cells, 55 it is possible that part of the proatherogenic effect of anti-CD4 depletion may be because of the loss of this protective influence, known to be more prominent during the time course of this experiment. 56 Indeed, in the aortic arch, but not the aortic root, there was still an (less prominent) increase in atherosclerosis after CD4 depletion in Ldlr A major protective influence of antibodies on atherosclerosis may derive from the clearance of oxLDL or secondary necrotic cellular debris. Consistent with this, the major observed difference in plaque composition in Ldlr −/− /Xbp1 cKO mice was a significant increase in TUNEL staining and necrotic core area ( Figure 5 ). As plaques progress, smooth muscle cells become increasingly synthetic and produce a fibrous cap of collagen important for plaque stability. 57 Here, the increased lesion size in the absence of antibodies was associated with decreased proportions of collagen. This further supports the hypothesis that a greater rate of lipid/dead cell accumulation led to enhanced atherosclerosis. IgM antibodies may only be important for efferocytosis in certain contexts, 58 for example, in atherosclerosis where pathways mediating rapid and early apoptotic cell uptake may be defective. Importantly, OSE-specific IgM have been shown to enhance the clearance of apoptotic cells by macrophages in vivo. 59, 60 Recently, increased antiphagocytic CD47 on the surface of plaque cells and loss of surface Mer tyrosine kinase on plaque phagocytes have been shown to play important roles in mouse and human atherosclerosis. 61, 62 These defects lead to secondary necrosis, making cells and oxLDL debris recognizable to anti-MDA and anti-phosphorylcholine antibodies. These antibodies provide an alternate protective layer that is nevertheless insufficient to prevent atherosclerosis progression; however, the lack of such antibodies greatly accelerates plaque growth.
The use of the bone marrow transfer model has both advantages and disadvantages and was reported to significantly modulate plaque development. 63 A developmental lack of antibodies and or B cells could have significant influence in lymphoid system development and, for example, alternative pathways that regulate apoptotic cell clearance may be upregulated. Such changes would be avoided using bone marrow transfer. However, bone marrow transfer also induces some changes in the B cell compartment, for example, in the balance between B1a and B1b cells in the periphery. Nevertheless, similar and corroborating findings from bone marrow transplant and nonbone marrow transplant studies involving B cells 29, 30 suggest this model continues to provide valuable information. Future studies are required to understand the specific contribution of CD4+ T cells and the relative atheroprotective contributions of antibody binding to oxLDL versus secondary necrotic cells.
In summary, the T cell-dependent humoral response can be protective. Our knowledge of the close reciprocal relationship between adaptive B and T cells, and links with innate responses, is rapidly evolving. This will enable not only novel and more advanced vaccine strategies for atherosclerosis, but will also help us to understand the impacts of the growing number of immunotherapies used in patients at high risk for cardiovascular disease.
